Breaking News, Collaborations & Alliances

Genmab Earns GSK Milestone

Files NDA in Japan for Arzerra

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Genmab A/S has received a $3.4 million milestone payment from GlaxoSmithKline related to the filing of the NDA to the Japanese Ministry of Health, Labor and Welfare (MHLW). The NDA is for Arzerra (ofatumumab) for the treatment of patients with chronic lymphocytic leukemia (CLL) who have received prior therapy....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters